What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

DNA Repair Mechanisms: An Overview for Students

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

DNA is the only macromolecule that is actively repaired rather than simply degraded and resynthesized when damaged. This distinction reflects the unique role of DNA as the repository of genetic information: a single unrepaired lesion can be permanently fixed into the genome as a mutation, whereas a damaged protein or RNA molecule can be replaced from the intact gene. The collection of biochemical pathways that detect, remove, and correct DNA damage is collectively termed DNA repair, and it constitutes one of the most evolutionarily conserved and physiologically critical systems in biology.

Introduction to DNA Repair

DNA repair encompasses all enzymatic processes that restore the chemical structure of DNA after damage. These pathways are not redundant backups of one another; rather, each is tailored to a specific class of chemical alteration. The importance of these systems is underscored by the phenotypes of their dysfunction: mutations in DNA repair genes cause hereditary cancer syndromes such as Lynch syndrome and xeroderma pigmentosum, and nearly all cancers exhibit some form of repair pathway alteration that contributes to their genomic instability.

Why DNA Repair Matters

The human genome sustains tens of thousands of damaging events per cell per day. Endogenous sources—reactive oxygen species from metabolism, spontaneous depurination, and replication errors—account for the majority. Exogenous sources include ultraviolet (UV) radiation, ionizing radiation, and environmental chemicals. Without repair, the mutation rate would be catastrophically high: estimates suggest that unrepaired damage would generate approximately one mutation per gene per cell division, a rate incompatible with organismal viability.

DNA repair also serves a second, less obvious function: it is a barrier to cancer development. The mutator phenotype hypothesis posits that acquisition of mutations in DNA repair genes accelerates the accumulation of further mutations, driving tumorigenesis. This is why inherited defects in repair pathways produce striking cancer predispositions, and why many chemotherapeutic agents work by overwhelming repair capacity.

Types of DNA Damage

DNA damage falls into several mechanistically distinct categories:

Base lesions: small chemical alterations such as oxidation (8-oxoguanine), deamination (uracil from cytosine), and alkylation (O6-methylguanine).
Bulky adducts: large chemical groups covalently attached to bases, such as UV-induced cyclobutane pyrimidine dimers (CPDs) and polycyclic aromatic hydrocarbon adducts.
Mismatches: correctly paired bases that are nonetheless incorrect (e.g., A–C), arising from replication errors.
Single-strand breaks (SSBs): discontinuities in one strand of the duplex.
Double-strand breaks (DSBs): discontinuities in both strands, the most cytotoxic lesion.
Crosslinks: covalent linkages between the two strands (interstrand crosslinks) or between bases on the same strand.

Each category is handled by a dedicated pathway or set of pathways, described below.

Direct Reversal of DNA Damage

Direct reversal is the simplest repair strategy: a single enzyme recognizes a specific lesion and chemically reverses it in a one-step reaction. This approach is energy-efficient and error-free because the original base is restored without excision or resynthesis. However, direct reversal is limited to a small number of lesion types.

Photoreactivation

Photoreactivation repairs UV-induced cyclobutane pyrimidine dimers (CPDs), the most common lesions from sunlight exposure. The enzyme photolyase binds to the CPD and, using energy from blue-light photons (300–500 nm), catalyzes the monomerization of the cyclobutane ring, restoring the two pyrimidines to their native state. Photolyase contains two chromophores: methenyltetrahydrofolate (MTHF) acts as a light-harvesting antenna, transferring energy to the catalytic cofactor FADH⁻, which donates an electron to the CPD to break the cyclobutane ring.

Photoreactivation is widespread in bacteria, fungi, plants, and many animals, but is absent in placental mammals, including humans. Humans instead rely exclusively on the excision pathways described below to handle UV damage. This loss is thought to reflect the redundancy of nucleotide excision repair in mammals.

O6-methylguanine repair

Alkylating agents, both endogenous (e.g., S-adenosylmethionine) and environmental (e.g., nitrosamines), can methylate the O6 position of guanine. The resulting O6-methylguanine mispairs with thymine during replication, generating G:C → A:T transition mutations. The enzyme O6-methylguanine-DNA methyltransferase (MGMT), also called alkylguanine transferase (AGT), directly transfers the methyl group from the damaged guanine to an active-site cysteine residue on the enzyme itself. This reaction is stoichiometric, not catalytic: the enzyme is irreversibly inactivated after a single repair event and must be degraded and resynthesized. MGMT is therefore sometimes called a "suicide enzyme."

MGMT expression varies between tissues and tumors, and this variation has clinical significance. In glioblastoma, high MGMT expression confers resistance to temozolomide, an alkylating chemotherapeutic, because the drug's cytotoxic lesions are rapidly removed. Conversely, methylation of the MGMT promoter—silencing its expression—is a favorable prognostic marker in these patients.

Base Excision Repair (BER)

Base Excision Repair (BER) handles the most frequent class of DNA damage: small, non-helix-distorting base lesions. These include oxidized bases (8-oxoguanine), deaminated bases (uracil, hypoxanthine), alkylated bases (3-methyladenine), and abasic sites. BER is initiated by a family of enzymes called DNA glycosylases, each with specificity for particular lesions.

Steps in BER

The BER pathway proceeds through five ordered steps:

Lesion recognition and base removal: A DNA glycosylase flips the damaged base out of the helix and cleaves the N-glycosidic bond, releasing the free base and leaving an apurinic/apyrimidinic (AP) site—a sugar-phosphate backbone with no base. Monofunctional glycosylases (e.g., uracil DNA glycosylase, UNG) create only the AP site. Bifunctional glycosylases (e.g., OGG1, which removes 8-oxoguanine) additionally possess AP lyase activity, cleaving the backbone 3′ to the AP site via a β-elimination reaction.

AP site processing: An AP endonuclease (APE1 in humans) cleaves the phosphodiester backbone 5′ to the AP site, generating a single-strand break with a 3′-hydroxyl and a 5′-deoxyribose phosphate (dRP) moiety. If a bifunctional glycosylase already created a 3′ nick, the AP endonuclease instead removes the 3′ blocking group.

End processing: The 5′ dRP group must be removed before DNA synthesis can occur. In short-patch BER, the dRP lyase activity of DNA polymerase β removes this group. In long-patch BER, the flap endonuclease FEN1 removes it as part of a displaced flap.

DNA synthesis: DNA polymerase β (Pol β) inserts a single nucleotide (short-patch) or several nucleotides (long-patch) to fill the gap. Pol β is uniquely suited for this role because it has both polymerase and dRP lyase activities.

Ligation: DNA ligase IIIα, in complex with the scaffold protein XRCC1, seals the nick. In long-patch BER, DNA ligase I performs the final ligation.

Short-patch vs. long-patch BER

BER operates in two sub-pathways that differ in the extent of synthesis:

Feature	Short-patch BER	Long-patch BER
Nucleotides replaced	1	2–13
Polymerase	Pol β	Pol β, Pol δ, or Pol ε
Flap processing	Not required	FEN1
Ligase	Ligase IIIα/XRCC1	Ligase I
Preferred lesions	Uracil, simple alkylation	Oxidized or reduced AP sites, lesions where the 5′ dRP is refractory to removal

The choice between short-patch and long-patch is determined by the chemical nature of the 5′ end. If the dRP group can be readily removed by Pol β's lyase activity, short-patch proceeds. If the sugar is oxidized or reduced, it cannot serve as a substrate for the lyase, and the pathway shifts to long-patch, which displaces the damaged sugar as part of a flap.

Nucleotide Excision Repair (NER)

Nucleotide Excision Repair (NER) handles bulky, helix-distorting lesions that BER cannot address. These include UV-induced photoproducts (CPDs and 6-4 photoproducts), bulky chemical adducts from environmental carcinogens (e.g., benzo[a]pyrene diol epoxide), and certain chemotherapeutic crosslinks (e.g., cisplatin adducts). The hallmark of NER is the removal of a short oligonucleotide (24–32 nucleotides) containing the lesion, followed by resynthesis using the undamaged strand as template.

Damage Recognition

NER is divided into two sub-pathways that differ only in the damage recognition step:

Global genomic NER (GG-NER): Operates throughout the genome. In humans, the XPC-RAD23B complex, assisted by the UV-damaged DNA-binding protein (UV-DDB), senses helix distortion. XPC binds to the strand opposite the lesion, recognizing the single-stranded character of the distorted duplex rather than the lesion itself.

Transcription-coupled NER (TC-NER): Operates on the transcribed strand of active genes. Here, the initiating signal is a stalled RNA polymerase II at the lesion. The proteins CSA and CSB (mutated in Cockayne syndrome) displace the polymerase and recruit the core NER machinery. TC-NER is faster than GG-NER and ensures that actively transcribed genes are preferentially repaired.

Incision and Excision

Once damage is recognized, the two sub-pathways converge. The transcription factor TFIIH, which contains the helicases XPB and XPD, unwinds the duplex around the lesion, creating a bubble of approximately 25 nucleotides. The endonucleases XPG (3′ incision) and ERCC1-XPF (5′ incision) then cleave the damaged strand, excising the lesion as part of a 24–32 nucleotide oligonucleotide. The precise spacing of the incisions—approximately 6 nucleotides 5′ and 20 nucleotides 3′ to the lesion—is dictated by the footprint of the repair complex.

Synthesis and Ligation

The resulting single-strand gap is filled by DNA polymerase δ or ε, with the accessory proteins PCNA and RPA. The final nick is sealed by DNA ligase I or ligase IIIα-XRCC1. Because the undamaged strand serves as template, NER is error-free.

The clinical importance of NER is illustrated by xeroderma pigmentosum (XP), a recessive disorder caused by mutations in any of seven NER genes (XPA through XPG). XP patients are hypersensitive to sunlight, have a >1000-fold increased risk of skin cancer, and often develop neurological degeneration due to accumulation of unrepaired damage in neurons.

Mismatch Repair (MMR)

Mismatch Repair (MMR) corrects replication errors that escape the proofreading activity of DNA polymerases. Despite the high fidelity of replicative polymerases (error rate ~10⁻⁵–10⁻⁶), the sheer number of nucleotides copied per cell division means that thousands of misincorporated bases occur. MMR reduces this error rate by an additional 100–1000-fold, bringing the overall mutation rate to approximately 10⁻⁹–10⁻¹⁰ per base pair per generation.

Recognizing Mismatches

In Escherichia coli, the system begins with the MutS homodimer, which scans the newly synthesized DNA for mismatches. MutS binds to the mismatch and undergoes an ATP-dependent conformational change that recruits MutL, a homodimer that acts as a molecular matchmaker. MutL activates MutH, an endonuclease that cleaves the unmethylated daughter strand at a nearby GATC sequence.

The key challenge in MMR is strand discrimination: the repair machinery must remove the incorrect base from the newly synthesized strand, not the correct base from the template strand. In E. coli, this is achieved through the transient hemimethylation of GATC sequences. The parental strand is methylated at adenine residues by the Dam methylase, while the newly synthesized strand is briefly unmethylated. MutH cleaves only the unmethylated strand, ensuring that repair is directed to the daughter strand.

Strand Discrimination

Humans lack the MutH-Dam methylation system and instead use a different mechanism for strand discrimination. Human MMR proteins are homologs of the bacterial system: MSH2-MSH6 (MutSα) recognizes base-base mismatches and small insertion/deletion loops, while MSH2-MSH3 (MutSβ) recognizes larger loops. The MutL homologs MLH1-PMS2 form the endonuclease that introduces a nick in the daughter strand.

In human cells, strand discrimination is thought to rely on the presence of pre-existing nicks in the newly synthesized strand, particularly at the 3′ ends of Okazaki Fragment on the lagging strand and at replication origins on the leading strand. The repair machinery loads onto the nick and excises the mismatch-containing DNA in the direction of the mismatch, using the 5′→3′ exonuclease EXO1. The single-strand binding protein RPA protects the exposed template, and the gap is filled by Pol δ and sealed by ligase I.

Defects in MMR cause Lynch syndrome (hereditary non-polyposis colorectal cancer), the most common hereditary colorectal cancer syndrome. MMR-deficient tumors exhibit a characteristic phenotype called microsatellite instability (MSI), reflecting the accumulation of insertion/deletion mutations in repetitive sequences.

Double-Strand Break Repair: Homologous Recombination and Non-Homologous End Joining

Double-strand breaks (DSBs) are the most dangerous form of DNA damage. A single unrepaired DSB can cause cell death, and misrepair can generate chromosomal translocations and deletions that drive carcinogenesis. Cells have two principal DSB repair pathways: homologous recombination (HR) and non-homologous end joining (NHEJ). These pathways differ fundamentally in their requirements for a template and their fidelity.

Homologous Recombination (HR)

Double Strand Break Repair via Homologous Recombination is an error-free pathway that uses the sister chromatid as a template. It is therefore restricted to the S and G2 phases of the cell cycle, when a sister chromatid is available.

The pathway proceeds through the following steps:

End resection: The MRN complex (MRE11-RAD50-NBS1) binds the DSB and, together with CtIP and EXO1, resects the 5′ ends to generate 3′ single-stranded DNA (ssDNA) overhangs. This resection is the key commitment step that directs repair toward HR rather than NHEJ.

RAD51 filament formation: The ssDNA is initially coated by RPA, which protects it from degradation. The recombinase RAD51, assisted by mediator proteins (BRCA2, RAD52), displaces RPA and forms a nucleoprotein filament.

Strand invasion: The RAD51-ssDNA filament searches for homologous sequences, typically on the sister chromatid, and invades the homologous duplex, displacing one strand to form a D-loop.

DNA synthesis and resolution: DNA polymerase extends the invading 3′ end using the homologous template. The resulting structures—double Holliday junctions—are resolved by nucleases and helicases (e.g., GEN1, MUS81-EME1, BLM-TOP3A-RMI1) to yield either crossover or non-crossover products. Alternatively, synthesis-dependent strand annealing (SDSA) can produce non-crossover products without Holliday junction formation.

The clinical importance of HR is highlighted by mutations in BRCA1 and BRCA2, which cause hereditary breast and ovarian cancer. These proteins are essential for RAD51 loading; their loss cripples HR, forcing cells to rely on error-prone NHEJ and promoting genomic instability.

Non-Homologous End Joining (NHEJ)

Non Homologous End Joining Repair is the dominant DSB repair pathway in G1 phase and in non-dividing cells. It directly ligates the two broken ends without requiring a homologous template. NHEJ is intrinsically error-prone because it often involves processing of the ends, leading to small insertions or deletions.

The core NHEJ pathway:

End binding: The Ku70/Ku80 heterodimer binds the DSB ends with high affinity, forming a ring that encircles the DNA. Ku serves as a platform for recruiting other NHEJ factors.

End bridging and processing: DNA-PKcs (the catalytic subunit of DNA-dependent protein kinase) is recruited and activated, bringing the two ends into proximity. If the ends are incompatible (e.g., containing damaged bases or overhangs), nucleases such as Artemis trim them, and polymerases (Pol μ and Pol λ) fill in gaps.

Ligation: The ligase complex XRCC4-DNA ligase IV, with the accessory protein XLF, seals the nick. The final product often contains small deletions or insertions at the junction.

Because NHEJ does not require a template, it can operate throughout the cell cycle. However, its error-prone nature means that it is a major source of mutations at DSB sites. In the immune system, NHEJ is deliberately used during V(D)J recombination to generate antibody and T-cell receptor diversity, and defects in NHEJ cause severe combined immunodeficiency (SCID).

The choice between HR and NHEJ is regulated by the cell cycle. In G1, CDK activity is low, resection is inhibited, and NHEJ predominates. In S/G2, CDK activity promotes resection, committing the break to HR. The decision is also influenced by the complexity of the break: simple, clean breaks are efficiently handled by NHEJ, while complex breaks with damaged ends often require HR.

Methods Used to Study DNA Repair

Studying DNA repair requires methods to induce damage, measure repair kinetics, and quantify the products. Several techniques are standard in the field.

Comet Assay

The comet assay (single-cell gel electrophoresis) measures DNA damage at the level of individual cells. Cells are embedded in agarose on a microscope slide, lysed to remove membranes and proteins, and subjected to electrophoresis under alkaline or neutral conditions. Damaged DNA fragments migrate toward the anode, forming a "comet tail" whose length and intensity are proportional to the amount of damage. The alkaline version detects single-strand breaks and alkali-labile sites, while the neutral version detects double-strand breaks. Repair can be measured by allowing cells to recover after damage and sampling at time points; the decrease in tail moment over time reflects repair capacity.

Reporter Constructs

Reporter assays measure repair of a specific lesion in a defined sequence context. A typical approach uses a plasmid or chromosomal construct containing a lesion at a known position within a reporter gene (e.g., lacZ or GFP). Cells are transfected with the damaged construct, and repair is scored by the restoration of reporter expression. For example, a GFP gene containing a site-specific UV lesion will not express functional GFP until NER removes the lesion and the gene is transcribed. The fraction of GFP-positive cells is proportional to repair efficiency.

Cell-based Assays

Cell-based assays measure the survival or mutation frequency of cells exposed to DNA-damaging agents. The clonogenic survival assay is the gold standard: cells are treated with increasing doses of a damaging agent (e.g., UV, ionizing radiation, or cisplatin), allowed to grow for 1–2 weeks, and colonies are counted. The surviving fraction is plotted against dose to generate a survival curve. Cells with defective repair show steeper survival curves (greater sensitivity). The hypoxanthine-guanine phosphoribosyltransferase (HPRT) mutation assay measures mutation frequency: cells are exposed to a mutagen, and mutants lacking HPRT activity are selected with 6-thioguanine. The mutant frequency reflects the balance between damage induction and repair.

Common Pitfalls and Misconceptions in DNA Repair

Students frequently encounter several conceptual difficulties when learning DNA repair. Recognizing these pitfalls is essential for accurate understanding.

BER vs. NER

The most common confusion is between BER and NER. Both pathways excise damaged bases, but they handle fundamentally different lesions. BER deals with small, non-helix-distorting lesions (oxidized bases, uracil, simple alkylation) and removes only the damaged base via glycosylases. NER deals with bulky, helix-distorting lesions (UV photoproducts, large adducts) and removes a 24–32 nucleotide oligonucleotide. A useful heuristic: if the lesion distorts the helix, it is a substrate for NER; if it is a small chemical change that does not distort the helix, it is a substrate for BER.

Error-prone vs. error-free repair

Another misconception is that all DNA repair is error-free. In reality, only pathways that use the undamaged strand as a template—BER, NER, MMR, and HR—are error-free. NHEJ is intrinsically error-prone, and direct reversal is error-free but limited to specific lesions. Moreover, cells possess translesion synthesis (TLS) polymerases that bypass damage during replication; these polymerases are highly error-prone and can introduce mutations at damaged sites. TLS is not a repair pathway per se, but it allows replication to proceed past lesions, and its activity is a major source of mutations induced by UV and chemical carcinogens.

Direct reversal is not universal

Students sometimes assume that direct reversal is a major pathway in humans. In fact, humans lack photolyase and rely on NER for UV damage. The only direct reversal enzyme of significance in humans is MGMT, which repairs O6-methylguanine. Direct reversal is more prominent in bacteria and plants.

MMR requires strand discrimination

A frequent misunderstanding is that MMR simply recognizes and removes mismatches. The critical feature is strand discrimination—the ability to distinguish the newly synthesized strand from the template. Without this, repair would be random and could fix the correct base into the template strand, converting a replication error into a permanent mutation. The bacterial MutH-Dam system and the human nick-directed mechanism both solve this problem, but they do so differently.

HR and NHEJ are not interchangeable

Students sometimes think that HR and NHEJ are redundant pathways that can substitute for one another. In reality, they are used in different cell cycle phases and have different outcomes. HR is restricted to S/G2 and is error-free; NHEJ operates throughout the cell cycle and is error-prone. The choice between them is tightly regulated, and inappropriate use of either pathway can be deleterious.

Frequently Asked Questions

What is DNA repair?

DNA repair is the collection of enzymatic pathways that detect and correct chemical damage to DNA. These pathways restore the original DNA sequence and structure, preventing mutations and maintaining genomic stability. Major pathways include direct reversal, base excision repair, nucleotide excision repair, mismatch repair, and double-strand break repair.

What are the main steps of DNA repair?

Most repair pathways follow a general scheme: (1) damage recognition, in which a sensor protein detects the lesion; (2) damage removal, in which the damaged base or nucleotide is excised; (3) gap filling, in which a DNA polymerase synthesizes new DNA using the undamaged strand as template; and (4) ligation, in which a DNA ligase seals the remaining nick. Double-strand break repair follows a different logic, either rejoining ends (NHEJ) or using a homologous template (HR).

How does DNA repair work?

DNA repair works through lesion-specific enzymes that recognize particular types of damage. For example, DNA glycosylases in BER recognize specific damaged bases, while the MutS protein in MMR recognizes mismatches. Once recognized, the damaged region is removed and resynthesized using the complementary strand as a template, ensuring that the original sequence is restored.

What are the stages of DNA repair?

The stages vary by pathway. BER proceeds through base removal, AP site processing, synthesis, and ligation. NER proceeds through damage recognition, dual incision, excision, synthesis, and ligation. MMR proceeds through mismatch recognition, strand discrimination, excision, synthesis, and ligation. HR proceeds through resection, filament formation, strand invasion, synthesis, and resolution. NHEJ proceeds through end binding, processing, and ligation.

Can DNA repair be enhanced?

In principle, DNA repair can be modulated, but enhancement is not straightforward. Overexpression of certain repair proteins, such as MGMT, can increase resistance to alkylating agents in experimental systems. However, enhanced repair is not always beneficial: cancer cells often upregulate repair pathways to resist chemotherapy, and inhibiting repair (e.g., with PARP inhibitors in BRCA-mutant tumors) is a therapeutic strategy. Lifestyle factors such as avoiding UV exposure and smoking reduce damage burden, indirectly preserving repair capacity.

What happens if DNA repair fails?

If DNA repair fails, damage persists and accumulates. During replication, unrepaired lesions can cause replication fork stalling, leading to double-strand breaks or mutations via translesion synthesis. The consequences include cell death, senescence, or transformation. Organismally, repair defects cause cancer predisposition syndromes (xeroderma pigmentosum, Lynch syndrome), neurodegeneration, and premature aging.

Is DNA repair always accurate?

No. Most repair pathways are error-free because they use the undamaged complementary strand as a template. However, NHEJ is error-prone and introduces small insertions or deletions at repair junctions. Additionally, translesion synthesis polymerases that bypass unrepaired damage are highly error-prone. The balance between error-free and error-prone processes determines the overall mutation rate.

Key Takeaways

DNA repair is essential for genomic stability; defects cause cancer predisposition and other hereditary diseases.
Direct reversal (photolyase, MGMT) is simple and error-free but limited to a few lesion types.
Base excision repair handles small base lesions via glycosylases and AP endonucleases, operating in short-patch and long-patch modes.
Nucleotide excision repair removes bulky, helix-distorting lesions as 24–32 nucleotide oligonucleotides, with dedicated sub-pathways for global and transcription-coupled repair.
Mismatch repair corrects replication errors and requires strand discrimination to target the newly synthesized strand.
Double-strand breaks are repaired by homologous recombination (error-free, S/G2 phase) or non-homologous end joining (error-prone, all cell cycle phases).
Experimental methods such as the comet assay, reporter constructs, and survival assays are essential tools for quantifying repair activity.